|
济川药业(600566)限售解禁 | 解禁日期 | 本期流通股本 (万股) | 本期流通股本占 总股本比例(%) | 已流通股本 (万股) | 未流通股本 (万股) | 流通A股 (万股) | 流通A股占 总股本比例(%) | 限售股类型 | 2025-09-08 | 242.96 | 0.26% | 91817.78 | 352.64 | 91574.82 | 99.35% | 股权激励限售股份 | 2021-04-26 | 7332.99 | 8.26% | 88825.79 | 0.00 | 88825.79 | 100.00% | 增发A股法人配售上市 | 2017-05-12 | 2816.93 | 3.48% | 80962.40 | 0.00 | 80962.40 | 100.00% | 增发A股法人配售上市 | 2016-12-26 | 61082.43 | 75.45% | 78145.47 | 2816.93 | 80962.40 | 100.00% | 增发A股法人配售上市 | 2015-02-12 | 3243.00 | 4.15% | 17063.04 | 61082.43 | 78145.47 | 100.00% | 增发A股法人配售上市 | 2011-12-06 | 2.34 | 0.02% | 13820.04 | 0.00 | 13820.04 | 100.00% | 股权分置限售流通 | 2009-04-13 | 1542.00 | 14.51% | 10629.00 | 1.80 | 10630.80 | 100.00% | 股权分置限售流通 | 2008-04-14 | 1552.38 | 14.60% | 9087.00 | 1543.80 | 10630.80 | 100.00% | 股权分置限售流通 | 2007-04-12 | 1594.62 | 15.00% | 7534.62 | 3096.18 | 10630.80 | 100.00% | 股权分置限售流通 |
|